Insider selling
Traded Nov 18 · filed 1 day laterNot reported under a pre-arranged trading plan
The CEO of CME sold $5.27M of CME shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 18, 2026 · Filed Nov 19, 2026
The CEO of CME sold $3.09M of CME shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$3,085,400
Shares × reported transaction price
28 days after results of Oct 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $310.25 on Nov 18, 2026, within 5% of its 52-week high, after a 15% rise over the previous 30 trading days
52-week range $218.58 (Jun 29, 2026) to $326.46 (Mar 2, 2026), 85% of the way up, from 251 adjusted closes. 30 trading days earlier: $270.27 on Oct 7, 2026. Describes the past only, not a forecast
RSI 59, 10% above its 200-day average, 8% above its 50-day average, 5% below the 52-week high, 20-day volatility 28% a year, against the S&P 500: +10 points over 1 month, +19 points over 3 months, +8 points over 6 months
From the adjusted closes up to Nov 18, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Jun 14, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
Global Carbon Opportunity (Cayman) Fund Ltd. v. CME Group Inc., docket 1:24-cv-04562, via CourtListener (court records). Nature of suit 850, company named as first defendant
Insider selling
Traded Nov 18 · filed 1 day laterNot reported under a pre-arranged trading plan
The CEO of CME sold $5.27M of CME shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 18 · filed 1 day laterNot reported under a pre-arranged trading plan
CME's Sr MD, General Counsel sold $204K of CME shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 18 · filed the same day
A CME officer told the SEC about a plan to sell $1.26M of CME shares around Nov 18, 2026. The shares were not acquired as compensation.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.